Skip to main content
. Author manuscript; available in PMC: 2015 Jan 20.
Published in final edited form as: Leuk Lymphoma. 2013 Nov 1;55(6):1332–1336. doi: 10.3109/10428194.2013.838764

Table I.

Dose-escalation of GTI-2040 in combination with high-dose AraC.

Dose level GTI-2040 CIVI days 1–6 (mg/kg/day) AraC IV q24 h days 2–6 (g/m2/dose) Cummulative dose AraC (g/m2) Number of patients treated
1 3.5 1.5 7.5 3
2 5 1.5 7.5 3
3 5 2 10 6
4 7 1.5 7.5 4

AraC, cytarabine; CIVI, continuous intravenous infusion.